We are live on ! Find out more
Vanguard Global Advisers

Vanguard Global Advisers Portfolio holdings

AUM $215B
This Fund
S&P 500
This Quarter Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
Cap. Flow
+$1.96B
Cap. Flow %
0.91%
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189M
2
HON icon
Honeywell
HON
+$157M
3
AAPL icon
Apple
AAPL
+$124M
4
MSFT icon
Microsoft
MSFT
+$89M
5
AMZN icon
Amazon
AMZN
+$62.1M

Sector Composition

Rank Sector Weight
1 Technology 25.83%
2 Miscellaneous 25.2%
3 Financials 11.43%
4 Communication Services 6.64%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
2726
Lineage Cell Therapeutics
LCTX
$229M
$112K ﹤0.01%
85,795
– –
AMX icon
2727
America Movil
AMX
$61.7B
$112K ﹤0.01%
4,317
+1,822
+73% +$47.9K
HTZ icon
2728
Hertz
HTZ
$624M
$112K ﹤0.01%
49,494
– –
RCKY icon
2729
Rocky Brands
RCKY
$343M
$112K ﹤0.01%
2,707
– –
NECB icon
2730
Northeast Community Bancorp
NECB
$359M
$112K ﹤0.01%
4,021
– –
FTK icon
2731
Flotek Industries
FTK
$1.06B
$111K ﹤0.01%
4,738
-11,616
-71% -$225K
EIKN
2732
Eikon Therapeutics
EIKN
$413M
$111K ﹤0.01%
8,484
-5,263
-38% -$53.7K
FC icon
2733
Franklin Covey
FC
$197M
$111K ﹤0.01%
4,512
– –
GNE icon
2734
Genie Energy
GNE
$432M
$109K ﹤0.01%
7,571
– –
IPSC icon
2735
Century Therapeutics
IPSC
$301M
$109K ﹤0.01%
44,616
– –
PALI icon
2736
Palisade Bio
PALI
$242M
$109K ﹤0.01%
52,292
– –
SLP icon
2737
Simulations Plus
SLP
$373M
$109K ﹤0.01%
5,967
– –
PINE
2738
Alpine Income Property Trust
PINE
$310M
$109K ﹤0.01%
5,257
– –
JACK icon
2739
Jack in the Box
JACK
$245M
$109K ﹤0.01%
6,893
– –
LXEO icon
2740
Lexeo Therapeutics
LXEO
$292M
$109K ﹤0.01%
23,385
-19,190
-45% -$104K
TSSI
2741
TSS Inc
TSSI
$272M
$109K ﹤0.01%
8,836
– –
LDI icon
2742
loanDepot
LDI
$202M
$109K ﹤0.01%
86,905
– –
PACK icon
2743
Ranpak Holdings
PACK
$350M
$109K ﹤0.01%
14,855
– –
GDRX icon
2744
GoodRx Holdings
GDRX
$1.1B
$109K ﹤0.01%
37,699
– –
TG icon
2745
Tredegar Corp
TG
$240M
$108K ﹤0.01%
13,604
– –
BOC icon
2746
Boston Omaha
BOC
$393M
$108K ﹤0.01%
7,925
-4,921
-38% -$61.9K
WEYS icon
2747
Weyco Group
WEYS
$477M
$108K ﹤0.01%
2,740
– –
OPFI icon
2748
OppFi
OPFI
$509M
$107K ﹤0.01%
10,744
– –
ACRE
2749
Ares Commercial Real Estate
ACRE
$214M
$107K ﹤0.01%
23,685
– –
LAB icon
2750
Standard BioTools
LAB
$288M
$106K ﹤0.01%
129,323
– –

Similar funds

Vanguard Global Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Financials.

  • Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
  • Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
  • Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
  • Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
  • Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
  • Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
  • Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.